The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 01, 2014

Filed:

May. 11, 2010
Applicants:

Mark Deem, Mountain View, CA (US);

Hanson Gifford, Iii, Woodside, CA (US);

Denise Demarais, Saratoga, CA (US);

Douglas Sutton, Pacifica, CA (US);

Erik Thai, San Jose, CA (US);

Mark Gelfand, New York, NY (US);

Howard R. Levin, Teaneck, NJ (US);

Inventors:

Mark Deem, Mountain View, CA (US);

Hanson Gifford, III, Woodside, CA (US);

Denise Demarais, Saratoga, CA (US);

Douglas Sutton, Pacifica, CA (US);

Erik Thai, San Jose, CA (US);

Mark Gelfand, New York, NY (US);

Howard R. Levin, Teaneck, NJ (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/00 (2006.01); A61B 18/18 (2006.01); A61N 1/05 (2006.01); A61N 1/36 (2006.01); A61B 18/14 (2006.01); A61N 5/00 (2006.01); A61N 1/04 (2006.01); A61B 18/00 (2006.01); A61N 7/00 (2006.01); A61N 1/32 (2006.01);
U.S. Cl.
CPC ...
A61N 5/00 (2013.01); A61B 18/18 (2013.01); A61B 2018/00434 (2013.01); A61N 1/05 (2013.01); A61N 1/36017 (2013.01); A61N 2007/003 (2013.01); A61B 2018/00505 (2013.01); A61B 18/1492 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/00613 (2013.01); A61N 1/326 (2013.01); A61B 2018/00511 (2013.01); A61N 1/3606 (2013.01); A61N 1/327 (2013.01); A61N 1/0412 (2013.01); A61B 2018/00404 (2013.01);
Abstract

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.


Find Patent Forward Citations

Loading…